Poland
· Delayed Price · Currency is PLN SDS Optic Spolka Akcyjna Company Description
SDS Optic Spolka Akcyjna discovers, develops, produces, and commercializes diagnostics and monitoring tools worldwide.
It offers inPROBE, a cancer diagnostics and treatment device that measure the level of active ingredients in cancer tumor cells.
The company is also involved in the modeling and designing of package components, such as ferrules, housings, and other devices with flat and conical surface areas.
In addition, it provides contract chemistry, molecular biology, multidisciplinary in vivo diagnostics and monitoring solutions development, comparative studies of biosimilar products, and early-stage in vivo and in vitro diagnostic technologies scale-up and commercialization services, as well as undertakes integrated multiple key-steps pre-clinical discovery projects.
The company was founded in 2013 and is based in Lublin, Poland.
| Country | Poland |
| Founded | 2013 |
| Industry | Biotechnology & Medical Research |
| Sector | Healthcare |
| CEO | Marcin Staniszewski |
Contact Details
Address: Centrum ECOTECH-COMPLEX Lublin, 20-612 Poland | |
| Phone | 48 81 501 9463 |
| Website | sdsoptic.pl |
Stock Details
| Ticker Symbol | SDS |
| Exchange | Warsaw Stock Exchange |
| Reporting Currency | PLN |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Marcin Staniszewski | Chief Executive Officer |
| Marta Geca | Chief Financial Officer |
| Karol Maryniowski | Head of Investor Relations |